Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds
BMJ
.
2023 Jun 8:381:1306.
doi: 10.1136/bmj.p1306.
Author
Jacqui Wise
1
Affiliation
1
Kent.
PMID:
37290779
DOI:
10.1136/bmj.p1306
No abstract available
MeSH terms
COVID-19*
Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents / adverse effects
Metformin* / therapeutic use
Substances
Metformin
Hypoglycemic Agents